Teeccino Is Ready for Explosive Growth
Teeccino, a coffee alternative, has achieved product-market fit and is looking for explosive growth in the coming years.
Profile picture of Teddy Lyons
Analyst Report: Upgrade for access Securisyn’s Tech Saves Patients’ Lives and Hospitals’ Bottom Lines
Using Securisyn's medical technology, hospitals should be able to both save lives and make better profits.
- Details
- Company: Securisyn Medical
- Security Type: SAFE
- Valuation: $40,000,000
- Min Investment: $100
- Platform: Republic
- Deadline: Dec 31, 2022
Andy Gordon - December 27th, 2022
Archaic Technology
Note: This recommendation was co-authored by KingsCrowd Investment Research Analyst Teddy Lyons.
I prefer to stay as far away from hospitals as possible.
Don’t get me wrong. I appreciate hospitals. But I also know that hospitals are businesses that are concerned with revenue and profit just like any other company. And that means that patient care is not always a top priority. This is America. We live in a capitalist, for-profit society. So I get it. But for some reason, knowing this about hospitals rubs me the wrong way.
I do give hospitals credit for having the most cutting-edge tools at their disposal, which is some consolation. That’s certainly true for imaging and surgical technology.
But what if I told you that there is an area of patient care where practitioners use tape as the main source of stabilization? Can’t be, right?
Well, that is precisely the case when it comes to the stabilization of breathing tubes used to keep ventilated patients alive. Tape! Let that sink in. Because it’s as bad as it sounds. Tape is so unstable that unplanned extubation (the accidental removal of a breathing tube from an airway) is associated with 33,000 preventable deaths each year in the United States.
The technology is archaic. In fact, it’s a joke. Somehow, no company has stepped forward to offer a product that can prevent the epidemic of endotracheal tube slippage and unplanned extubation.
Until now.
The company I’m introducing to you today — Securisyn Medical — has patented a tube stabilization device that solves the life-threatening issues surrounding unplanned extubation and tube slippage.
For hospitals, this is huge. Any opportunity to lower fatality rates is an obvious reason to purchase a product like SolidAIRity Flex, Securisyn’s flagship breathing stabilization product.
And because the product never enters the body, Securisyn’s products do not need FDA approval. That’s a big investing risk off the table.
Pay Annually - save 17%
save 17%
This content requires: Edge
Data-driven startup investment ratings, AI analyst reports, and portfolio company exit and failure tracking
$
15
/month
12.50
/annually
What's included
- Everything in Free plus
- Data-driven investment ratings and AI analyst reports
- Advanced company search table (with ratings and reports)
- Markets page filters and historical industry data
- Startup investment exit and failure tracker
- Startup Portfolio Tracking
- Follows
- Advanced Search Table
- Founder Profiles
- Trending Companies
- Fundraising Analytics
- News and Crowdopedia
Advanced Search table full access, including ratings and analyst reports.
Charts and trends of capital raised by platform, security type, industry, and more.
Unlock Ratings and AI analyst report filters in the Advanced Company Search.
Track IPOs, acquisitions, failures and other exits for companies in your portfolio.
